Table 1.
Baseline clinical, hemodynamic and laboratory variables of patients without and with angina.
Table 2.
Timing (days) from diagnostic procedures to enrollment, median (IQR).
Fig 1.
Cardiovascular drugs† prescribed at the end of the visit or at hospital discharge in patients with and without angina.
†Drugs not reported have been used in less than 5% of cases. ACE-I: angiotensin converting enzyme inhibitors; ARB: angiotensin receptor blockers; ASA: acetylsalicylic acid; DAPT: dual antiplatelet therapy; MRA: mineralocorticoid receptor antagonist; OAT: oral anticoagulation therapy.
Fig 2.
Use of combinations of angina relief drugs in patients with and without angina.
βB: beta-blockers; CCBs: calcium channel blockers.
Fig 3.
Domain of movement ability (panel A), body care (panel B), daily activities (panel C), pain/worry (panel D), and anxiety/depression (panel E) of the EQ 5D-5L questionnaire in patients with and without angina.